Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. - Wikidata - awgldk - TriplyDB

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q44595957

about

Neoadjuvant chemotherapy versus none for resectable gastric cancer Neoadjuvant chemotherapy versus none for resectable gastric cancer Multimodal treatment of gastric cancer in the west: Where are we going?The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamou Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer.Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction.Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.Sequential expression of putative stem cell markers in gastric carcinogenesis.Multiphoton microscopy for tumor regression grading after neoadjuvant treatment for colorectal carcinoma Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study.Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.Investigation of the potential role of preoperative chemotherapy in treatment for gastric cancer with outlet obstruction.ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.Trimodal therapy in squamous cell carcinoma of the esophagus.Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study.Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy.Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer.Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas.The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.The relationship between Lin28 and the chemotherapy response of gastric cancer

P2860

Q24243367-85381ECE-80DB-4E7B-8C8F-9A70D2785248 Q24245439-57381F81-FE28-40A2-8C5B-89AC926BDF13 Q26799748-0F445A8A-C1BC-435C-A764-C3360C30D296 Q27687612-9C129244-9626-4066-AB8F-8627C8AC1B5D Q28088619-7A784E88-7084-4F0E-B14C-95DB951C3180 Q33612711-610F1A15-5468-4047-85CB-6E8A4574BD17 Q33656736-4E472490-5CE6-426C-BB3F-6703B5FC2998 Q33728359-BEEBED16-5C39-4F46-B225-6DF98AABE178 Q33850915-1BF40142-2F35-4EED-B3DC-6878F825716B Q33942343-8796943D-330B-4BBB-9AFC-6D75DA398BD0 Q34390923-49EF07AC-1488-4479-ACB2-95566D5441E4 Q34581435-1AA15539-94FB-4276-A760-B01D5F65F168 Q35059969-59A1D7A4-C02C-421C-A5E1-31842BB051F0 Q35060024-52D4DDC7-C6EF-4C9B-A093-FE5232580FE0 Q35287614-CC68D6C0-3043-4D7B-B272-6A90B48BE791 Q35375442-531C7EC2-7DC6-4549-8972-176CDD91133F Q35375517-63B08B08-750C-4D70-A73E-2BCB9425F1A0 Q35555993-1AA6BA6A-F4D5-44ED-B019-C36BD48A68AD Q35583933-AD5DB21F-DB9B-4735-BE65-B620F95AC9CD Q35633809-AB454D45-05CC-4A75-981A-D825E91809BE Q35948035-3DF3F953-22ED-4040-9815-AABDE247184E Q36082155-25AC9322-0E9B-4A0D-89C0-1920B7AF490C Q36100983-2A2DE35D-B9F3-4A4B-BEBE-F97E59181723 Q36105835-1C9A6CEE-549C-4991-A2FF-874D3A4BC916 Q36172227-5CC45C63-D1C3-426B-B55A-DBFE970E33ED Q36249303-ADCA5CAE-A82A-403C-9F05-0B76066B0DAA Q36307739-043D3F06-DCA3-4A01-B31F-E0ED8B72CCBC Q36322912-1629EBE0-3A28-4CD9-90FF-2A3204DFC048 Q36333418-73C02ED7-47C6-4CE3-A031-558023CBBCF2 Q36401587-CC7E7655-DEFB-4646-967A-D727CB307C55 Q36406800-B82C9693-779C-44D1-B0B9-0085783FCA79 Q36596436-274DD460-84F3-41AB-BD62-D50B24290D0A Q36610597-97C27B5A-253F-4762-8AF1-AEEE07AF9731 Q36936039-DE35704A-2661-4F81-B754-7F6B0DBFC27E Q37040615-227A5D0E-969B-4F1D-AA01-F69232F325A6 Q37076617-7EA80B6C-6C73-45AD-99B4-FD3B31494F77 Q37174037-45624563-AB74-4AED-864F-2051D131646A Q37187705-5F742D3F-1C25-4D3E-AA5E-14AA013321A2 Q37204825-E489A44F-94E0-4CCD-B69B-20C1751740D5 Q37213326-7F765D35-0A82-4F50-88C5-26976B5ECEC0

P2860

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q44595957

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@en

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@nl

type

label

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@en

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@nl

prefLabel

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@en

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@nl

P1433

Q44595957-863B8833-C1BE-4995-8D04-D5E3956BE862

P1476

Q44595957-30726835-A0AD-4675-93EB-7E569E27C941

P2093

Q44595957-8524AB3A-DC5C-475D-BB3B-689921E79752

Q44595957-9934EC7F-8BE5-4697-816E-CCCA638FAC7D

Q44595957-A9F26ED3-0BB9-4260-A654-3CF4A1DE9B45

Q44595957-ABADAD56-9736-4A4F-8CDF-C9EA00CF32A5

Q44595957-C03D10C0-EE2F-4538-AD0D-6A0C8AFA140F

Q44595957-C4C200EF-62D0-41CF-A9CB-0567AC5E283B

Q44595957-C55B5F83-2135-4648-9B5C-AA7CDD6EC9AE

Q44595957-D7EB9564-5ADB-42C2-90A4-CCFC6B7FC46B

Q44595957-F66337C7-A76C-45F0-BC91-831E601FBA0E

P304

Q44595957-CF3A017B-023C-4780-9CE7-08ECE239E6FB

P31

Q44595957-3329742E-DA82-4E86-8667-672BBC32C9F7

P356

Q44595957-2E0EEAF6-4E40-40C3-8E87-0706DAEAC3B0

P407

Q44595957-E3BFD0FC-A5AC-4FE4-AE52-D33914CA73C4

P433

Q44595957-A72EA86C-57DD-44A5-85E5-5158A266F65D

P478

Q44595957-31CD2F61-D3F3-46C6-B4EB-8D9888305181

P577

Q44595957-80592BD6-962A-4BB7-B5F2-43BE15389CA8

P5875

Q44595957-1A1A2D7D-9C6A-4921-8C3A-8D9936C95904

P698

Q44595957-B37EE94B-5B00-4910-86C3-AC5810F05D95

P921

Q44595957-846615FB-510C-4548-99AC-A63307C1F82B

P356

P1433

P1476

Histomorphology and grading of ...... with neoadjuvant chemotherapy.

@en

P2093

Christoph Schulmacher

http://www.w3.org/2001/XMLSchema#string

Heinz Höfler

http://www.w3.org/2001/XMLSchema#string

J Rüdiger Siewert

http://www.w3.org/2001/XMLSchema#string

James D Mueller

http://www.w3.org/2001/XMLSchema#string

Karen Becker

http://www.w3.org/2001/XMLSchema#string

Katja Ott

http://www.w3.org/2001/XMLSchema#string

Knut Böttcher

http://www.w3.org/2001/XMLSchema#string

Raymonde Busch

http://www.w3.org/2001/XMLSchema#string

Ulrich Fink

http://www.w3.org/2001/XMLSchema#string

P304

1521-1530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11660

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9080787

http://www.w3.org/2001/XMLSchema#string

P698

14508841

http://www.w3.org/2001/XMLSchema#string

P921